Infectious Agents and Cancer
[Accessed 05 Dec 2020]
FDA efficiency for approval process of COVID-19 therapeutics
Authors: Christine Cassidy, Danielle Dever, Laura Stanbery, Gerald Edelman, Lance Dworkin and John Nemunaitis
1 December 2020
This review article examines the expedited FDA review process for remdesivir and hydroxychloroquine, and analyzes data and results from early clinical studies of both drugs.